Author:
Walker Shelley,Curtis Michael,Kirwan Amy,Thatcher Rebecca,Dietze Paul
Abstract
Abstract
Background
Primary needle and syringe programs (NSPs) have been integral for the prevention of blood-borne virus (BBV) transmission among people who inject drugs. Despite this, many people who inject drugs face barriers accessing these services, particularly after-hours when most services are closed. To our knowledge, the St Kilda NSP, in Melbourne, Victoria, is the only primary NSP providing 24/7 dedicated stand-alone face-to-face services for people who inject drugs in Australia. We conducted an evaluation of the St Kilda NSP to assess its role and effectiveness in meeting client needs.
Methods
Mixed research methods were used to conduct the evaluation. We analysed four quantitative data sets including the Victorian Needle and Syringe Program Information System data; NSP ‘snapshot’ survey data; and St Kilda NSP records of after-hours contacts and naloxone training events. Qualitative interviews were conducted with 20 purposively selected NSP clients, which were focused on individual needs, expectations and experiences accessing the service. Interviews were audio recorded and transcribed, and data were analysed thematically. A convergent research design was used to merge the five data sets.
Results
St Kilda NSP had 39,898 service contacts in 2018; 72% of contacts occurred outside business hours. Similarly, of 1,185,000 sterile needles and syringes dispatched, 71% were distributed outside business hours. Participants described valuing the after-hours service because drug use patterns did not always align with standard NSP opening hours and after-hours access afforded anonymity when collecting injecting equipment. Narratives highlighted several additional benefits of the 24/7 service, including: access to safer sex equipment; material support; naloxone training; referrals to specialist services; face-to-face emotional and social support from a non-judging worker; and for women involved in sex work in particular, being able to seek refuge when feeling unsafe on the streets.
Conclusions
Our study provides evidence of the social and health benefits (beyond that of preventing BBV transmission) that can be gained through the provision of 24/7 primary NSP services. Findings support the need for the establishment of after-hours primary NSPs in other areas of Australia where active street-based drug markets operate outside business hours and concentrated numbers of people who inject drugs live and spend time.
Funder
The Salvation Army Territory Australia
Publisher
Springer Science and Business Media LLC
Reference53 articles.
1. Wodak A, Cooney A. Do needle syringe programs reduce HIV infection among injecting drug users: a comprehensive review of the international evidence. Subst Use Misuse. 2006;41(6–7):777–813. https://doi.org/10.1080/10826080600669579.
2. Carrotte E, Dietze P, Kirwan A. Syringe coverage and Australian NSPs. Melbourne (AUST): Centre for Research Excellence into Injecting Drug Use; 2015. https://creidu.edu.au/system/policy_document/12/pdf/Policy_Brief_Kirwan_Syringe_coverage.pdf.
3. O’Keefe D, Ritter A, Stoove M, Hughes C, Dietze P. Harm reduction programs and policy in Australia: barriers and enablers to effective implementation. Sucht. 2020;66(1):33–43. https://doi.org/10.1024/0939-5911/a000641.
4. Heard S, Iversen J, Geddes L, Kwon JA, Maher L. Needle syringe program national minimum data collection: 2021 National data report 2021. Sydney (AUST): Kirby Institute; 2021. https://www.kirby.unsw.edu.au/research/projects/ansps.
5. Sweeney S, Ward Z, Platt L, Guinness L, Hickman M, Hope V, et al. Evaluating the cost-effectiveness of existing needle and syringe programmes in preventing hepatitis C transmission in people who inject drugs. Addiction. 2019;114(3):560–70. https://doi.org/10.1111/add.14519.